In vitro proizvodnja neuraminidaze bakterije Clostridium chauvoei soja Jakari. by Nicodemus Maashin Useh et al.
289
VETERINARSKI ARHIV 74 (4), 289-298, 2004
* Contact address:
Dr. Nicodemus Maashin Useh, Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Ahmadu
Bello University, Zaria, Nigeria, Phone: +234 069 551358; E-mail: nickuseh@yahoo.com
ISSN 0372-5480
Printed in Croatia
 In vitro production of neuraminidase by Clostridium chauvoei
(Jakari strain)
Nicodemus Maashin Useh1*, Andrew Jonathan Nok2, Ologunja
Joseph Ajanusi3, Emmanuel Oluwadare Balogun2, Sunday Blessing
Oladele1, and King Akpofure Nelson Esievo1
USEH, N. M., A. J. NOK, O. J. AJANUSI, E. O. BALOGUN, S. B. OLADELE,
K. A. N. ESIEVO: In vitro production of neuraminidase by Clostridium
chauvoei (Jakari strain). Vet. arhiv 74, 289-298, 2004.
ABSTRACT
The production of neuraminidase (sialidase, EC 3.2.1.18) by Clostridium chauvoei (Jakari strain)
was investigated and a novel neuraminidase was detected in the bacterium in vitro using a fluorescent
substrate. Neuraminidase activity was reproducible and had a linear relationship with the amount of
bacteria at lower bacterial concentrations. The relationship was no longer linear at higher bacterial
concentrations (3.33×107 to 4.44×107 cfu/ml). The possible role of this enzyme in the pathogenesis of
blackleg disease is discussed. It is concluded that the enzyme could be playing the role of spreading
the disease in the tissues of infected ruminants. Therefore, the use of neuraminidase inhibitors to
manage the disease clinically should be thoroughly investigated.
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Introduction
Neuraminidases (sialidases, EC 3.2.1.18) belong to a class of glycosyl
hydrolases that release terminal N-acetylneuraminic (sialic) acid residues
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from glycoproteins, glycolipids and polysaccharides (ROGGENTIN et al.,
1993). These are key enzymes of sialic acid catabolism, hydrolyzing the
glycosidic linkage between sialic acid molecules and the penultimate sugar
of the carbohydrate chains of oligosaccharides and glycoconjugates. These
enzymes have been detected in a variety of microorganisms such as viruses,
bacteria and protozoa (MULLER, 1974; ESIEVO, 1979; PEREIRA, 1983; SAITO
and YU, 1993; OLADELE et al., 2002). For some microbial pathogens, sialidases
are believed to act as virulence factors, allowing successful competition
with the host by alleviating their spread in host tissue (GODOY et al., 1993).
Blackleg, which is a disease of cattle, sheep and other ruminants, was
first reported in Nigeria by 1929, cited by OSIYEMI, 1975) and has remained a
major problem of cattle in the country. Nigeria’s epidemiologists classify
the disease as a “List A disease” in the country, because of the very high
mortality rates associated with it at the onset of the rainy season
(ABDULKADIR, 1989). Although vaccination against the disease has been
carried out since 1930 (OSIYEMI, 1984), many sporadic outbreaks have been
recorded annually. The nomadic Fulani Pastoralists of rural Nigeria who
own about 70-80% of total livestock in the country (SULEIMAN, 1988) prefer
the use of traditional (herbal) remedies to manage blackleg. Most of them
still have reservations about the use of conventional drugs to manage the
disease (ABDU et al., 2000). The use of neuraminidase inhibitors to clinically
manage infectious diseases, whose aetiologic agents produce
neuraminidase, has been advocated (HAYDEN et al., 1997). This study was
therefore conducted to investigate the production of neuraminidase by
Clostridium chauvoei (Jakari strain) in vitro to provide a clear
understanding on the pathogenesis of blackleg disease and we report here,
for the first time, that the bacteria produce neuraminidase.
Materials and methods
Reagents. All the reagents used in this experiment were purchased
from Sigma Chemical Company, St. Louis, U.S.A. Media (agar) for
bacterial cultivation were procured from Oxoid Company, England.
Bacterial strain. Clostridium chauvoei (Jakari strain) was obtained in
its lyophilized form from the National Veterinary Research Institute, Vom,
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Plateau State, Nigeria for this experiment. The bacterium was isolated
from clinically infected Zebu cattle and its pathogenicity indices have been
fully determined (PRINCEWILL, 1965).
Media preparation. Three media were used for cultivating Clostridium
chauvoei (Jakari strain) to assay for neuraminidase activity, namely:
reinforced clostridial medium (RCM), blood agar (BA) and cooked meat
medium (CMM). The media were prepared by modifying the methods
described by DOWELL and HAWKINS (1981) with all procedures for
microbiological asepsis strictly adhered to.
RCM was prepared by weighing Bacteriological peptone (1%), meat
extract (1%), yeast extract (0.3%), Sodium Chloride (0.5%), Sodium acetate
(0.8%), agar base (0.05%), soluble starch (0.1%), L-cysteine hydrochloride
(0.06%) and D- Glucose (0.6%), respectively, into a conical flask using a
sensitive balance (Medical market®) and with the addition of 100 ml of
distilled water. The mixture was autoclaved at 121 oC, 15 pounds pressure,
for 15 minutes. The pH of the medium was adjusted to 8.4 after cooling.
Ten ml of the prepared RCM was dispensed into sterile bottles and kept at
4 oC to be used on the same day it was prepared.
BA was prepared by weighing 37 g of agar base (powder) into a 2-
litre-capacity beaker containing 1 litre of distilled water and allowed to
soak for 10 minutes. This was swirled for proper mixing, sterilized as
stated earlier and allowed to cool to 47 oC before adding 5% defibrinated
sheep blood. The sheep blood was properly mixed with the remaining
content of the beaker before pouring the prepared BA onto plates. After
drying, the BA was used on the same day.
Commercially prepared CMM was reconstituted by weighing 237 g
into a 2.5-litre-capacity beaker and 1.9 litres of distilled water added to it.
This was left to soak for 20 min. after which the mixture was autoclaved
as described earlier for RCM and BA before being allowed to cool to
room temperature. The reconstituted CMM was placed in an incubator
and used the following day.
Bacterial cultivation. One glass ampoule of Clostridium chauvoei
(Jakari strain) was severed using a pair of sterile scissors. Aliquots (0.5
ml) of RCM was transferred from a sterile bottle containing 10 ml of RCM
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into the glass ampoule using a sterile 2 ml syringe, rinsed and emptied
back into it. This was then placed in an incubator at 37 oC for 48 hours to
reactivate the lyophilized bacteria. Thereafter, the reactivated bacteria were
removed from the incubator and 4 drops were placed on a blood agar plate
using a Pasteur pipette. This was incubated for 48 hours to identify the
colonies of Clostridium chauvoei (Jakari strain). Pure colonies of the
reactivated bacteria in 10 ml RCM were transferred into a 2.5 litre sterile
culture bottle containing 1.9 litres of CMM and placed in a gaspak anaerobic
jar, whose lid was screwed until it became hand tight. The anaerobic jar
and its contents were placed in the incubator at 37 oC for 72 hours.
Microbiological asepsis was maintained at each stage of bacterial
cultivation.
Serial dilution. One ml of culture supernatant was pipetted and used
for serial dilution. A 10- fold dilution was carried out (NORTON, 1986).
Nine ml of cysteine-glucose-peptone water (CGPW) was dispensed into
sterile McIntire bottles of 20 ml capacity and labelled 1 to 7. The 1 ml of
culture supernatant earlier pipetted was transferred to McIntire bottle
number 1, mixed well; subsequently, 1 ml was transferred from the
preceding bottle to the next up to the 7th sterile bottle. Using a sterile
micropipette, 4 drops of the content of bottles number 1 to 7 (serially
diluted 10-fold) were transferred to sterile blood agar plates labelled 1 to
7 respectively and incubated anaerobically at 37 oC for 24 hours using
gaspak anaerobic jar. The colonies on blood agar plates 6 and 7 were
counted and their averages computed and expressed as number of colonies
per ml of culture (colony-forming units per ml, i.e. cfu/ml). Each
micropipette drop on blood agar plate is equivalent to 50 µl capacity and
hence 50 was used as the factor to compute the amount of bacteria (cfu/
ml) in the culture. At each stage of the experiment, microbiological asepsis
was strictly maintained.
Processing of culture medium. CMM containing the cultivated bacteria
was placed in a refrigerated centrifuge (Mistral 4L, MSE) and spun at
9,000 g for 40 minutes at 4 oC. The supernatant was decanted immediately
into two sterile plastic containers each of 1 litre capacity. The plastics
containing the culture supernatant were kept at -20 oC until required.
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Ammonium sulphate [(NH4)2SO4] fractionation of culture supernatant.
Three ml each of culture supernatant were dispensed into test tubes
containing 168 mg, 210 mg, 528 mg, 726 mg, 939 mg, 1.053 g, 1.17 g,
1.416 g and 2.46 g of (NH4)2 SO4 corresponding to 10, 20, 30, 40, 50, 55,
60, 70, and 80% (NH4)2 S04 saturation respectively. These tubes were set
in duplicates. The mixture was then homogenized by violent agitation to
apparent homogeneity and centrifuged using a refrigerated centrifuge
(Beckman, Model J-21 B) at 20,000 g at 4 oC for 30 minutes. The
supernatants were decanted using Pasteur pipette, and 1 ml of phosphate
buffered saline (PBS, pH 6.8) was added to each sediment. Neuraminidase
activity was assayed in the various fractions as described below to
determine the presence of enzyme activity and the fractions with the highest
enzyme activity. There was enzyme activity in all the fractions, and was
highest in the region of 55-70% (NH
4
)2SO4 saturation. The enzyme fractions
in this region were pooled as follows for dialysis: Five hundred ml of
culture supernatant was added to 175.5 g of (NH
4
)2SO4 in a beaker and
properly homogenized as described earlier. This was then spun in a
refrigerated centrifuge (MSE, Mistral 4 L) at 9,000 g at 4 oC for 40 minutes.
The supernatant was decanted and saved, as A, while 15 ml of 50 mM
sodium acetate buffer, pH 5.5 was added to the sediment. A further 51.5 g
of (NH
4
)2SO4 was added to the saved supernatant mentioned above and
allowed to dissolve properly as earlier described, and spun in a refrigerated
centrifuge at 9,000 g at 4 oC for 40 minutes. The supernatant was decanted
and finally discarded, while the sediment saved as B was mixed with A.
The mixture is the pooled fraction of the culture supernatant at 55-70%
(NH4)2SO4 saturation containing pooled neuraminidase.
Dialysis of pooled culture supernatant.Thirty ml of this supernatant
was pipetted into a 20-cm long and 6-cm diameter dialysis bag and placed
in a 2-litre capacity dialysis beaker containing 1.5 litres of 50 mM sodium
acetate buffer, pH 4.5. The dialysis beaker and its contents were placed on
a speed plate magnetic stirrer at 4 oC overnight against three changes of
the same buffer.
Neuraminidase assay. This was carried out using a fluorescent substrate
(KLENNEIDAM et al., 2001). Aliquots (50 µl) of the substrate 4-Methyl
Umbelliferyl-Neuraminic acid (4-MU-Neu5Ac) at a final concentration
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of 0.7 mM in 50 mM sodium acetate buffer, pH 5.5, was incubated with 50
µl of the dialyzed culture supernatant at 37 0C for 30 min. At the end of the
incubation period the reaction was terminated using 0.5 M borate buffer,
pH 9.8. The released methylumbelliferone was then measured at 525 nm
excitation and 490 nm emission with a multiple Hitachi fluoroscan. For
each determination, the spectrofluorimeter was calibrated with pure
methylumbelliferone as standard and readings were corrected by
subtracting dialyzed culture supernatant and substrate blanks. One unit of
enzyme activity was defined as the amount of enzyme that hydrolyses 1
mM 4-MU-Neu5Ac per minute under the described assay conditions. This
procedure was repeated 50 times to test for reproducibility.
Results and discussion
A bacterial concentration of 1.11 × 109 cfu/ml Clostridium chauvoei
(Jakari strain) was obtained after serial dilution. It was observed during
the study that the bacteria produced neuraminidase in vitro and the
neuraminidase was extra-cellular, released in CMM during bacterial
growth. The results of amount of bacteria and neuraminidase activity are
presented in Fig. 2. There was a linear relationship between neuraminidase
activity and amount of bacteria at lower bacterial concentrations. The
relationship was no longer linear at higher bacterial concentrations (3.33
× 107 to 4.44 × 107 cfu/ml). This accords with the findings of ESIEVO et al.
(1982), who also reported a linear relationship between Trypanosoma vivax
lysates and neuraminidase activity in vitro at lower concentrations of
trypanosome lysates. These workers established that the loss in linearity
could be due to substrate exhaustion. The culture supernatant was partially
purified through ammonium sulphate saturation and dialysis.
Neuraminidase activity was assayed in all the (NH4)2SO4 fractions (10-
80%) and activity was highest between 55-70% (NH4)2SO4 saturation (Fig.
1). This region of highest enzyme activity was pooled before dialysis to
obtain maximum enzyme activity, and this approach is hereby presented
as a model for obtaining maximum neuraminidase activity from Clostridium
chauvoei.
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The terminal sialic acid from sugar residues and glycoproteins is
cleaved by the enzyme neuraminidase, while the detection of the
neuraminidase rests on the assay of free sialic acid split from the substrate
(WEBSTER and CAMPBELL, 1972; NOK and BALOGUN, 2003). In the present
study, a substrate that is specific for neuraminidase (4-MU-Neu5Ac) was
used to detect neuraminidase activity in Clostridium chauvoei (Jakari strain)
because neuraminidase is the only enzyme that cleaves sialic acid from
this substrate to produce the classical pink colour that characterises its
presence. Based on the report of ESIEVO (1980) that the neuraminidase of
Trypanosoma vivax cleaved erythrocyte surface sialic acids in clinical
infections, it is thought safe to assume that if Clostridium chauvoei (Jakari
strain) do produce neuraminidase in vitro, the same may be applicable if
























Fig. 1. Ammonium sulphate fractionation curve of Clostridium chauvoei (Jakari strain)
neuraminidase
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In conclusion, this study shows that Clostridium chauvoei (Jakari strain)
produce neuraminidase in vitro and it is therefore suggested that the enzyme
could be playing the role of spreading blackleg disease in the tissues of
infected ruminants by cleaving their sialic acids to facilitate the spread. It
is expedient to clinically assess the therapeutic efficacy of neuraminidase
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Fig. 2. Expression of neuraminidase as a function of the concentration of Clostridium
chauvoei (Jakari strain)
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SAŽETAK
Dokazana je proizvodnja neuraminidaze (sialidaze, EC 3.2.1.18) bakterije Clostridium chauvoei
soja Jakari in vitro pomoæu fluorescentnog supstrata. Aktivnost neuraminidaze bila je reproducibilna
uz linearni odnos kolièine bakterija pri nižim bakterijskim koncentracijama. Taj omjer nije bio linearan
pri višim bakterijskim koncentracijama (3,33 x 107 do 4,44 x 107 cfu/ml). Raspravlja se o moguæoj
ulozi ovog enzima u patogenezi šuštavca. Zakljuèeno je da bi enzim mogao imati ulogu u širenju
bolesti kroz tkiva inficiranih preživaèa. Uporaba inhibitora neuraminidaze u kontroli bolesti trebala
bi biti potpunije istražena.
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